Bronchoscope Market Report 2025

The bronchoscope market size has grown strongly in recent years. It will grow from $2.95 billion in 2024 to $3.23 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing awareness and acceptance, medical training and education, clinical applications and endobronchial interventions, demand for minimally invasive techniques, aging population dynamics.

The bronchoscope market size is expected to see rapid growth in the next few years. It will grow to $5.04 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to rising respiratory disorders, growing aging population, demand for minimally invasive procedures, advancements in robotics, focus on early diagnosis. Major trends in the forecast period include miniaturization and portability, focus on patient safety and comfort, augmented reality (AR) and navigation systems, telemedicine and remote guidance, disposable bronchoscopes.

The increasing prevalence of respiratory tract disorders is expected to drive the growth of the bronchoscope market in the future. Respiratory tract disorders are medical conditions that impact the respiratory system, including asthma, chronic obstructive pulmonary disease (COPD), pneumonia, bronchitis, cystic fibrosis, pulmonary fibrosis, and lung cancer. Bronchoscopy serves as a diagnostic and therapeutic tool that can evaluate and treat various respiratory tract disorders; therefore, the rise in these conditions is likely to lead to increased demand for bronchoscopes. For instance, in June 2024, a report from the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, stated that in 2023, COPD accounted for 3.6% of the total disease burden and 50% of the burden from respiratory conditions. Additionally, it was reported that 87% of COPD patients in 2022 had one or more comorbidities, with the most prevalent being mental and behavioral conditions (49%), arthritis (45%), and asthma and back problems (42% each). Therefore, the rise in the prevalence of respiratory tract disorders is anticipated to enhance the bronchoscope market.

The growing demand for minimally invasive procedures is expected to drive the growth of the bronchoscope market in the future. Minimally invasive procedures (MIPs) are surgical interventions conducted through small incisions in the body. Minimally invasive bronchoscopy provides several advantages, including reduced invasiveness, patient preference, advancements in diagnostics and therapeutics, faster recovery times, and lower complication rates. The development of advanced instruments, such as flexible and video bronchoscopes, enhances the precision and effectiveness of these procedures. For example, in September 2023, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional organization for board-certified aesthetic plastic surgeons, reported an 11.2% increase in procedures performed by plastic surgeons in 2022, with over 14.9 million surgical and 18.8 million non-surgical procedures carried out globally. Thus, the rising demand for minimally invasive procedures is driving the growth of the bronchoscope market.

Major companies in the bronchoscope market are developing innovative products, such as slim outer diameter bronchoscopes, to improve patient comfort, enhance access to distal airways, and optimize diagnostic and therapeutic capabilities in minimally invasive procedures. Slim bronchoscopes feature a narrow design that facilitates easier access to smaller airways and increases patient comfort during procedures. For example, in May 2024, Olympus Corporation, a Japan-based medical technology and optics company, launched bronchoscopes compatible with the EVIS X1 endoscopy system. The BF-H1100 and BF-1TH1100 bronchoscopes are equipped with high-definition imaging and a slim outer diameter to improve access to distal airways. The BF-H1100 includes a 2.2mm working channel, providing an 11% increase in suction, while the BF-1TH1100 has a 3.0mm working channel with a 29% suction increase. Both models feature a redesigned image sensor for HDTV resolution and incorporate advanced imaging technologies, such as BAI-MAC, TXI, RDI, and NBI, which enhance diagnostic accuracy in bronchoscopic procedures.

Major companies in the bronchoscope market are concentrating on developing advanced robotics with real-time imaging to improve diagnostic accuracy, reduce patient discomfort, and shorten recovery times during lung disease diagnosis and treatment. Advanced robotics with real-time imaging involves robotic systems that utilize live imaging technologies to guide precise actions and decision-making in real-time. For example, in September 2024, TidalHealth Nanticoke, a US-based healthcare organization, launched an advanced robotic bronchoscopy system using the Ion platform to enhance the diagnosis and treatment of lung diseases. This cutting-edge technology offers high-definition visualization and precision for less invasive lung tissue biopsies, allowing specialists to navigate complex bronchial passages more effectively.

In May 2022, Medtronic plc, an esteemed medical devices company based in Ireland, completed the acquisition of Intersect ENT for an undisclosed sum. This strategic move significantly broadened Medtronic's portfolio within the ear, nose, and throat (ENT) segment by integrating innovative sinus implant products such as PROPEL and SINUVA from Intersect ENT. These additions enhance Medtronic's capacity to provide a more comprehensive range of care for individuals coping with chronic rhinosinusitis (CRS), fortifying its foothold in the global healthcare technology market. Intersect ENT, a US-based medical device manufacturer, specializes in developing drug-delivery devices tailored for ear, nose, and throat (ENT) conditions.

Major companies operating in the bronchoscope market include Ambu A/S, Boston Scientific Corporation, Cogentix Medical Inc., Cook Medical LLC, Fujifilm Holdings Corporation, Hoya Corporation, Karl Storz Endoscopy SE & Co. KG, Olympus Corporation, PENTAX Medical, Richard Wolf GmbH, Teleflex Incorporated, EFER Endoscopy Srl, Lymol Medical Corporation, Schindler Endoskopie Technology GmbH, Schölly Fiberoptic GmbH, Uptake Medical B.V., Broncus Medical Inc., Novatech SA, Shanghai AoHua Photoelectricity Endoscope Co. Ltd., Rochling Group, Stryker Corporation, NeoScope Inc., Bryan Corporation, CONMED Corporation, Laborie Medical Technologies Corp., Envision Endoscopy Inc., SonoScape Medical Corp., Verathon Inc., Medtronic plc.

North America was the largest region in the bronchoscope market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bronchoscope market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bronchoscope market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A bronchoscope is a vital medical instrument employed to visually examine the lungs and airways. It comprises a flexible or rigid tube equipped with a camera and light source at its tip, enabling physicians to observe the trachea, bronchi, and bronchioles. This device serves both diagnostic and therapeutic purposes, facilitating procedures such as tissue biopsy, foreign object removal, and various airway medical interventions.

Two primary variants of bronchoscopes exist, rigid and flexible. Rigid bronchoscopes, crafted from metal and composed of handles, tubes, and sheaths, find application in diagnosing and treating respiratory conditions. They are instrumental in procedures including foreign body extraction, tumor excision, stent insertion, biopsy, hemostasis, and laser therapy. Bronchoscopes come in reusable and disposable forms, catering to diagnostic and treatment needs across hospital settings, clinics, ambulatory surgical centers, and similar medical facilities.

The bronchoscope market research report is one of a series of new reports that provides bronchoscope market statistics, including bronchoscope industry global market size, regional shares, competitors with a bronchoscope market share, detailed bronchoscope market segments, market trends and opportunities, and any further data you may need to thrive in the bronchoscope industry. This bronchoscope market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bronchoscope market consists of sales of fiber optic bronchoscopes and video bronchoscopes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.